http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019031489-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e61866e714198ee02a24037c9670828
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2018-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce89654d7017f9ad0bd3e3cebb55cc69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91567311d7093c01da860bf703247ef0
publicationDate 2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2019031489-A
titleOfInvention Tablets containing esomeprazole magnesium hydrate
abstract [PROBLEMS] To improve the stability of an active ingredient in a preparation. [MEANS FOR SOLVING PROBLEMS] The present invention improves the stability of an active ingredient in a preparation by adopting a specific substance as a component of the preparation. One embodiment of the present invention is a formulation (eg, a tablet) comprising sodium starch glycolate, low substituted hydroxypropyl cellulose or crospovidone as a specific disintegrant. The active ingredient of the preparation of the present invention includes a proton pump inhibitor (for example, esomeprazole), a salt thereof, or a hydrate thereof. [Selection figure] None
priorityDate 2017-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419498817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9579578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453335048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454445837
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419569664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152732532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9568614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9568613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192113
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6338572
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450426460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634

Total number of triples: 43.